American Century Companies’s Protara Therapeutics TARA Stock Holding History

American Century Companies's TARA Position: Q2 2026 in Review

American Century Companies increased its Protara Therapeutics (TARA) stake by 5.9% in Q2 2026, buying an estimated $26.2K and bringing the position to 98,487 shares worth $376K. The position accounts for ﹤0.01% of the portfolio, ranked #2655.

American Century Companies first reported a position in TARA in Q1 2025 and has held it in 6 quarters since. The position peaked at $484K in Q1 2026. 111 funds tracked by Wall St. Rank hold TARA as of Q2 2026.

• American Century Companies held 98,487 shares of Protara Therapeutics worth $376K as of Q2 2026.
• American Century Companies bought 5,518 Protara Therapeutics shares in Q2 2026, an estimated $26.2K.
• Protara Therapeutics made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2655 holding.
• American Century Companies first reported a position in Protara Therapeutics in Q1 2025 and has held it in 6 quarters since.
• American Century Companies's Protara Therapeutics position peaked at $484K in Q1 2026.
• 111 funds tracked by Wall St. Rank held Protara Therapeutics as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.